Wednesday, November 25, 2009 1:01:45 AM
Vernier's experience in data analysis combined with Bio-Rad's Biotechnology Explorer (TM) program kits and curricula provide state-of-the-art solutions to biotechnology education
BEAVERTON, Ore., Nov. 18 /PRNewswire/ -- Vernier Software & Technology, a provider of educational science interfaces, sensors, and software and Bio-Rad Laboratories, Inc., a multinational manufacturer and distributor of life science research and clinical diagnostics products that include its Biotechnology Explorer(TM) program, are combining their respective expertise in science education products to offer an enhanced biotechnology curricula for educators as well as students at the high school and college-level.
The newly combined curriculum will bring together Vernier's instructor-friendly data-acquisition equipment with Bio-Rad's industry-standard Biotechnology Explorer program kits and equipment. An example of the curriculum being developed features instructional tools that allow teachers to utilize Bio-Rad's lab activities for bacterial transformation and DNA electrophoresis in conjunction with Vernier's Blue and White Digital Bioimaging Systems and Logger Pro Software.
"Students need a real-world, high-end lab experience to learn these complex concepts," said David Vernier, Vernier co-founder and a former physics teacher. "This partnership combines the expertise of both organizations to create lab experiences that are easy for instructors to implement. We believe partnering with Bio-Rad will allow us to better meet the needs of life science instructors at the high school and college levels."
Vernier and Bio-Rad are currently offering workshops on their new solutions and presented a joint workshop at the National Association of Biology Teachers (NABT) conference in Denver in November 2009. For more information about these events, visit http://www.vernier.com/workshops.
About Vernier Software & Technology
Vernier Software & Technology has been an innovator of data-collection technology for 28 years. Creating easy-to-use and affordable science interfaces, sensors, and software, their products can be found in education from elementary school to college. Vernier helps teachers enhance their science curriculum, increase learning, and build students' critical thinking skills. Vernier's technologies are in use worldwide in more than 125 countries. For more information visit http://www.vernier.com/.
Bio-Rad Laboratories
Bio-Rad Laboratories, Inc. (NYSE:BIONYSE:andNYSE:BIOb) has remained at the center of scientific discovery for more than 50 years, manufacturing and distributing a broad range of products for the life science research and clinical diagnostic markets. The company is renowned worldwide among hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies for its commitment to quality and customer service. Founded in 1952, Bio-Rad is headquartered in Hercules, California, and serves more than 85,000 research and industry customers worldwide through its global network of operations. The company employs over 6,500 people globally and had revenues exceeding $1.7 billion in 2008. For more information, please visit http://www.bio-rad.com/.
DATASOURCE: Vernier Software & Technology
CONTACT: Daylene Long, Vernier Software & Technology, +1-503-277-2299,
; Julie Mathern, Bio-Rad Laboratories, +1-510-741-6347,
; Kati Elliott, KEH Communications, +1-410-975-9638,
Web Site: http://www.vernier.com/
http://www.bio-rad.com/
http://ih.advfn.com/p.php?pid=nmona&cb=1259128408&article=40422799&symbol=NY%5EBIO
Recent BIO News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/09/2024 08:30:20 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/08/2024 08:38:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 08:31:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 06:25:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:18:26 PM
- Bio-Rad Reports First-Quarter 2024 Financial Results • Business Wire • 05/07/2024 08:15:00 PM
- Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference • Business Wire • 05/01/2024 01:00:00 PM
- Bio-Rad Announces Life Science Group Management Changes • Business Wire • 04/26/2024 12:30:00 PM
- Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024 • Business Wire • 04/18/2024 01:00:00 PM
- Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay • GlobeNewswire Inc. • 04/11/2024 09:30:00 PM
- Bio-Rad’s Chief Operating Officer Andrew Last to Retire • Business Wire • 04/10/2024 08:15:00 PM
- Bio-Rad Appoints Roop K. Lakkaraju Executive Vice President, Chief Financial Officer • Business Wire • 03/20/2024 12:30:00 PM
- Bio-Rad to Participate in Fireside Chat During Citi's 2024 Unplugged Medtech and Life Sciences Access Day • Business Wire • 02/22/2024 09:30:00 PM
- Bio-Rad Reports Fourth-Quarter and Full-Year 2023 Financial Results • Business Wire • 02/15/2024 09:15:00 PM
- Bio-Rad to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 15, 2024 • Business Wire • 01/24/2024 10:00:00 PM
- Bio-Rad’s Management to Host Investor Meetings at J.P. Morgan’s 42nd Annual Healthcare Conference • Business Wire • 01/02/2024 09:15:00 PM
- Bio-Rad Reports Third-Quarter 2023 Financial Results • Business Wire • 10/26/2023 08:15:00 PM
- Bio-Rad to Report Third Quarter 2023 Financial Results on Thursday, October 26, 2023 • Business Wire • 10/05/2023 12:30:00 PM
- Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference • Business Wire • 08/28/2023 08:15:00 PM
- Bio-Rad Reports Second-Quarter 2023 Financial Results • Business Wire • 08/03/2023 08:15:00 PM
- Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement • Business Wire • 07/26/2023 08:15:00 PM
- Bio-Rad Announces New Share Repurchase Program • Business Wire • 07/20/2023 08:30:00 PM
- Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023 • Business Wire • 07/10/2023 08:30:00 PM
- Bio-Rad Publishes Corporate Sustainability Report for 2022 • Business Wire • 07/10/2023 01:00:00 PM
- Bio-Rad to Present Company Overview at Jefferies Healthcare Conference • Business Wire • 06/01/2023 12:00:00 PM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM